Figure 3From: Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain Active lesion at the final visit. Initial fundus (a) of a patient followed for 4 years showed neither blood nor lipidic exudates and logMAR VA was 0.7(20/100); b) fluorescein angiography displayed an occult CNV. The patient needed 4 injections de 1st year, 2 along the 2nd year, 1 during the 3rd year, and none during the 4th year until the last visit in which a reactivation was observed with blood in fundus picture (c) and subretinal fluid in OCT (d). Final VA was 0.4 logMAR (20/50).Back to article page